Table 2.
The classification results of three models built using radiomics analysis, clinical and imaging characteristics, and the combined model (high VEGF and mutant p53 as positive).
| Sensitivity | Specificity | Accuracy | AUC | ||
|---|---|---|---|---|---|
| High vs. low VEGF* | Radiomics analysis | 44/49 (90%) | 27/31 (87%) | 71/80 (89%) | 0.88 |
| Clinical + imaging | 44/49 (90%) | 15/31 (48%) | 64/80 (80%) | 0.81 | |
| Combined model | 41/49 (84%) | 27/31 (87%) | 68/80 (85%) | 0.88 | |
| Mutant vs. Wild-type p53 | Radiomics analysis | 7/12 (58%) | 68/68 (100%) | 75/80 (94%) | 0.79 |
| Clinical + imaging | 5/12 (42%) | 61/68 (90%) | 66/80 (83%) | 0.72 | |
| Combined model | 7/12 (58%) | 64/68 (94%) | 71/80 (89%) | 0.77 |
*VEGF, vascular endothelial growth factor. Low group includes grades 0 and 1 and high group includes grades 2 and 3.